Intrahepatic Signals Involve in the Recruitment and Differentiation of IL-17 Secreting T Cells and Regulatory T Cells in Chronic Hepatitis - Fellowship

Research output

Research output per year 2012 2012 2016 2021

• 38 Article
• 1 Review article

Research output per year

Research output per year

Search results

• 2019

  NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune Response

  Lutz, P., Jeffery, H. C., Jones, N., Birtwistle, J., Kramer, B., Nattermann, J., Spengler, U., Strassburg, C. P., Adams, D. H. & Oo, Y. H., 7 Aug 2019, In: Frontiers in immunology. 10, AUG, 1838.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Ascites 100%
  • Natural Killer Cells 93%
  • Liver Diseases 85%
  • Phenotype 60%
  • Liver 24%
  200 Downloads (Pure)
• 2018

  Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis

  Jeffery, H. C., Braitch, M. K., Bagnall, C., Hodson, J., Jeffery, L. E., Wawman, R. E., Wong, L. L., Birtwistle, J., Bartlett, H., Lohse, A. W., Hirschfield, G. M., Dyson, J., Jones, D., Hubscher, S. G., Klenerman, P., Adams, D. H. & Oo, Y. H., 1 Apr 2018, In: Hepatology Communications. 2, 4, p. 421-436

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Autoimmune Hepatitis 100%
  • Regulatory T-Lymphocytes 78%
  • Natural Killer Cells 73%
  • Adrenal Cortex Hormones 63%
  • Memory 57%
  183 Downloads (Pure)

• Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells

  Atif, M., Warner, S. & Oo, Y. H., Jul 2018, In: Hepatology International. 12, 4, p. 305-314

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Regulatory T-Lymphocytes 100%
  • Mucosal-Associated Invariant T Cells 83%
  • Mucous Membrane 80%
  • T-Lymphocytes 62%
  • Liver 51%
  9 Citations (Scopus)

  214 Downloads (Pure)

• Regulatory T Cell Metabolism in the Hepatic Microenvironment

  Wawman, R. E., Bartlett, H. & Oo, Y. H., 8 Jan 2018, In: Frontiers in immunology. 8, 1889.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Regulatory T-Lymphocytes 100%
  • Liver 51%
  • T-Lymphocytes 31%
  • Organ Transplantation 27%
  • Metabolic Networks and Pathways 25%
  17 Citations (Scopus)

  235 Downloads (Pure)
• 2017

  Human intrahepatic ILC2 are IL-13^*positive Amphiregulin^*positive and their frequency correlates with Model of End stage Liver Disease score

  Jeffery, H., McDowell, P., Lutz, P., Wawman, R. E., Roberts, S., Bagnall, C., Birtwistle, J., Adams, D. & Oo, Y. H., 19 Dec 2017, In: PLoS ONE. 12, 12, e0188649.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Intrahepatic 100%
  • interleukin-13 91%
  • Amphiregulin 89%
  • liver diseases 78%
  • End Stage Liver Disease 70%
  25 Citations (Scopus)

  154 Downloads (Pure)

• Low dose interleukin-2 promotes STAT5 phosphorylation, Treg survival and CTLA-4 dependent function in autoimmune liver disease: Low dose IL2 promotes regulatory T cell function in autoimmune liver diseases

  Jeffery, H., Jeffery, L., Lutz, P., Corrigan, M., Webb, G., Hirschfield, G., Adams, D. & Oo, Y. H., 9 May 2017, In: Clinical & Experimental Immunology. 188, 3, p. 394–411

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • aldesleukin 100%
  • Regulatory T-Lymphocytes 53%
  • Interleukin-2 48%
  • Autoimmune Diseases 46%
  • Liver Diseases 45%
  32 Citations (Scopus)

  166 Downloads (Pure)
• 2016

  Autoimmune Hepatitis: progress from global immunosuppression to personalised regulatory T Cell therapy

  Than, N. N., Jeffery, H. C. & Oo, Y. H., 2016, In: Canadian Journal of Gastroenterology and Hepatology. 2016, 12 p., 7181685.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Autoimmune Hepatitis 100%
  • Regulatory T-Lymphocytes 78%
  • Cell- and Tissue-Based Therapy 74%
  • Immunosuppression 71%
  • Liver 27%
  20 Citations (Scopus)

• Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1

  Jeffery, H. C., van Wilgenburg, B., Kurioka, A., Parekh, K., Stirling, K., Roberts, S., Dutton, E. E., Hunter, S., Geh, D., Braitch, M. K., Rajanayagam, J., Iqbal, T., Pinkney, T., Brown, R., Withers, D. R., Adams, D. H., Klenerman, P. & Oo, Y., May 2016, In: Journal of Hepatology. 64, 5, p. 1118–1127

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Mucosal-Associated Invariant T Cells 100%
  • B-Lymphocytes 46%
  • Epithelium 45%
  • Bacteria 40%
  • Liver 30%
  91 Citations (Scopus)

  239 Downloads (Pure)

• Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans

  Kelly, C., Swadling, L., Capone, S., Brown, A., Richardson, R., Halliday, J., von Delft, A., Oo, Y. H., Mutimer, D., Kurioka, A., Hartnell, F., Collier, J., Ammendola, V., Del Sorbo, M., Grazioli, F., Luisa Esposito, M., Di Marco, S., Siani, L., Traboni, C., Hill, A. V. S., & 6 othersColloca, S., Nicosia, A., Cortese, R., Folgori, A., Klenerman, P. & Barnes, E., May 2016, In: Hepatology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Chronic Hepatitis C 100%
  • Hepacivirus 88%
  • Immunity 77%
  • Vaccines 71%
  • Virus Diseases 70%
  29 Citations (Scopus)

• Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives

  Jeffery, H., Braitch, M., Brown, S. & Oo, Y. H., 6 Sept 2016, In: Frontiers in immunology. 7, 334.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Regulatory T-Lymphocytes 100%
  • Cell- and Tissue-Based Therapy 95%
  • Liver Diseases 84%
  • Chronic Hepatitis 80%
  • Autoimmune Diseases 43%
  25 Citations (Scopus)

  220 Downloads (Pure)

• Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance

  Hübener, S., Oo, Y. H., Than, N. N., Hübener, P., Weiler-Normann, C., Lohse, A. W. & Schramm, C., Mar 2016, In: Clinical Gastroenterology and Hepatology. 14, 3, p. 445–453

  Research output: Contribution to journal › Article › peer-review

  • Mercaptopurine 100%
  • Autoimmune Hepatitis 95%
  • Azathioprine 83%
  • Immunosuppressive Agents 12%
  • Therapeutics 12%
  50 Citations (Scopus)

• Erratum to: The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019)

  Gardenbroek, T. J., Pinkney, T. D., Sahami, S., Morton, D. G., Buskens, C. J., Ponsioen, C. Y., Tanis, P. J., Löwenberg, M., van den Brink, G. R., Broeders, I. A. M. J., Pullens, H. J. M., Seerden, T., Boom, M. J., Mallant-Hent, R. C., Pierik, R. E. G. J. M., Vecht, J., Sosef, M. N., van Nunen, A. B., van Wagensveld, B. A., Stokkers, P. C. F., & 16 othersGerhards, M. F., Jansen, J. M., Acherman, Y., Depla, A. C. T. M., Mannaerts, G. H. H., West, R., Iqbal, T., Pathmakanthan, S., Howard, R., Magill, L., Singh, B., Oo, Y. H., Negpodiev, D., Dijkgraaf, M. G. W., D'Haens, G. R. A. M. & Bemelman, W. A., 4 Jan 2016, In: JAMA Surgery. 16, 1, p. 1

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Citation (Scopus)

• Flares during long-term entecavir therapy in chronic hepatitis B

  Chi, H., Arends, P., Reijnders, J. G. P., Carey, I., Brown, A., Fasano, M., Mutimer, D., Deterding, K., Oo, Y. H., Petersen, J., van Bommel, F., de Knegt, R. J., Santantonio, T. A., Berg, T., Welzel, T. M., Wedemeyer, H., Buti, M., Pradat, P., Zoulim, F., Hansen, B., & 2 othersJanssen, H. L. A. & VIRGIL Surveillance Study Group, 24 Mar 2016, In: Journal of Gastroenterology and Hepatology.

  Research output: Contribution to journal › Article › peer-review

  • entecavir 100%
  • Chronic Hepatitis B 75%
  • Viruses 31%
  • Hepatitis B e Antigens 27%
  • Incidence 22%
  9 Citations (Scopus)

• HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression

  Chen, L., Gu, L., Gu, Y., Wang, H., Deng, M., Stamataki, Z., Huang, Y. & Oo, Y. H., 25 Oct 2016, In: Scientific Reports. 6, 35917.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • S-Phase Kinase-Associated Proteins 100%
  • Hepatitis B virus 59%
  • Hepatocellular Carcinoma 49%
  • Up-Regulation 43%
  • Mutation 34%
  7 Citations (Scopus)

  137 Downloads (Pure)

• Hepatocellular carcinoma surveillance in hepatitis B virus-infected individuals: Who and how?

  Li, K-K., Trivedi, P. J., Von Heimendahl, S., Bruns, T., Ward, S. T., Oo, Y. H. & Mutimer, D., Apr 2016, In: Hepatology. 63, 4, p. 1394-1395 2 p.

  Research output: Contribution to journal › Article › peer-review

• Human intrahepatic T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis

  Chen, Y-Y., Jeffery, H. C., Hunter, S., Bhogal, R., Birtwistle, J., Kaur Braitch, M., Roberts, S., Ming, M., Hannah, J., Thomas, C., Adali, G., Hubscher, S., Syn, W-K., Afford, S., Lalor, P. F., Adams, D. H. & Oo, Y. H., Jul 2016, In: Hepatology. 64, 1, p. 138–150 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Fas Ligand Protein 100%
  • Interleukin-2 73%
  • Cell Survival 62%
  • T-Lymphocytes 50%
  • Apoptosis 50%
  44 Citations (Scopus)

  204 Downloads (Pure)

• Long-term corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease

  Krishnamoorthy, T. L., Miezynska-Kurtycz, J., Hodson, J., Gunson, B., Neuberger, J., Milkiewicz, P. & Oo, Y. H., Jan 2016, In: Liver Transplantation. 22, 1, p. 34–41

  Research output: Contribution to journal › Article › peer-review

  • Autoimmune Hepatitis 100%
  • Liver Transplantation 71%
  • Adrenal Cortex Hormones 63%
  • Osteoporosis 58%
  • Sepsis 42%
  28 Citations (Scopus)

• Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy

  Than, N. N., Wiegard, C., Weiler-Normann, C., Füssel, K., Mann, J., Hodson, J., Hirschfield, G. M., Lohse, A. W., Adams, D. H., Schramm, C. & Oo, Y. H., Mar 2016, In: Scandinavian Journal of Gastroenterology. 51, 3, p. 329-336 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Autoimmune Hepatitis 100%
  • Tacrolimus 85%
  • Immunosuppression 12%
  • Therapeutics 12%
  • Immunoglobulin G 10%
  40 Citations (Scopus)

• MAIT cells are activated during human viral infections

  van Wilgenburg, B., Scherwitzl, I., Hutchinson, E. C., Leng, T., Kurioka, A., Kulicke, C., de Lara, C., Cole, S., Vasanawathana, S., Limpitikul, W., Malasit, P., Young, D., Denney, L., Moore, M. D., Fabris, P., Giordani, M. T., Oo, Y., Laidlaw, S. M., Dustin, L. B., Ho, L-P., & 7 othersThompson, F. M., Ramamurthy, N., Mongkolsapaya, J., Willberg, C. B., Screaton, G. R., Klenerman, P. & STOP-HCV consortium, 23 Jun 2016, In: Nature Communications. 7, 11653.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Mucosal-Associated Invariant T Cells 100%
  • infectious diseases 75%
  • Virus Diseases 44%
  • activation 39%
  • viruses 35%
  220 Citations (Scopus)

  176 Downloads (Pure)

• Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis

  Coombes, J. D., Choi, S. S., Swiderska-Syn, M., Manka, P., Reid, D. T., Palma, E., Briones-Orta, M. A., Xie, G., Younis, R., Kitamura, N., Della Peruta, M., Bitencourt, S., Dollé, L., Oo, Y. H., Mi, Z., Kuo, P. C., Williams, R., Chokshi, S., Canbay, A., Claridge, L. C., & 3 othersEksteen, B., Diehl, A. M. & Syn, W-K., Jan 2016, In: Biochimica et Biophysica Acta. 1862, 1, p. 135-144 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Osteopontin 100%
  • Effector 91%
  • Fatty Liver 90%
  • Leptin 83%
  • Fibrosis 62%
  26 Citations (Scopus)

  385 Downloads (Pure)

• Single-gene association between GATA-2 and autoimmune hepatitis: a novel genetic insight highlighting immunologic pathways to disease

  Webb, G., Chen, Y-Y., Li, K-K., Neil, D., Oo, Y. H., Richter, A., Bigley, V., Collin, M., Adams, D. H. & Hirschfield, G. M., May 2016, In: Journal of Hepatology. 64, 5, p. 1190–1193

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Autoimmune Hepatitis 100%
  • Genes 31%
  • flt3 ligand protein 29%
  • Mutation 16%
  • Transcription Factors 14%
  13 Citations (Scopus)

  246 Downloads (Pure)
• 2015

  Autoimmune hepatitis: an approach to disease understanding and management

  Corrigan, M., Hirschfield, G. M., Oo, Y. H. & Adams, D. H., Jun 2015, In: British Medical Bulletin. 114, 1, p. 181-91 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Autoimmune Hepatitis 100%
  • Disease Management 78%
  • End Stage Liver Disease 23%
  • Azathioprine 21%
  • Serology 20%
  20 Citations (Scopus)

• Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

  Arends, P., Sonneveld, M. J., Zoutendijk, R., Carey, I., Brown, A., Fasano, M., Mutimer, D., Deterding, K., Reijnders, J. G. P., Oo, Y. H., Petersen, J., van Bömmel, F., de Knegt, R. J., Santantonio, T., Berg, T., Welzel, T. M., Wedemeyer, H., Buti, M., Pradat, P., Zoulim, F., & 3 othersHansen, B., Janssen, H. L. A. & VIRGIL Surveillance Study Group, Aug 2015, In: Gut. 64, 8, p. 1289-95 7 p.

  Research output: Contribution to journal › Article › peer-review

  • entecavir 100%
  • Chronic Hepatitis B 75%
  • Hepatocellular Carcinoma 56%
  • Therapeutics 11%
  • Statistics 7%
  128 Citations (Scopus)

• Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice

  Coombes, J. D., Swiderska-Syn, M., Dollé, L., Reid, D., Eksteen, B., Claridge, L., Briones-Orta, M. A., Shetty, S., Oo, Y. H., Riva, A., Chokshi, S., Papa, S., Mi, Z., Kuo, P. C., Williams, R., Canbay, A., Adams, D. H., Diehl, A. M., van Grunsven, L. A., Choi, S. S., & 1 othersSyn, W. K., Jul 2015, In: Gut. 64, 7, p. 1120-31 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Osteopontin 100%
  • Stem Cells 61%
  • Liver 43%
  • Liver Cirrhosis 20%
  • Hedgehogs 14%
  53 Citations (Scopus)
• 2014

  Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T-cell apoptosis

  Afford, S. C., Humphreys, E. H., Reid, D. T., Russell, C. L., Banz, V. M., Oo, Y. H., Vo, T., Jenne, C., Adams, D. H. & Eksteen, B., May 2014, In: Hepatology. 59, 5, p. 1932-1943 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Vascular Cell Adhesion Molecule-1 100%
  • Epithelium 66%
  • T-Lymphocytes 53%
  • Apoptosis 52%
  • Inflammation 51%
  34 Citations (Scopus)
• 2013

  Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics

  Liaskou, E., Zimmermann, H. W., Li, K-K., Oo, Y. H., Suresh, S., Stamataki, Z., Qureshi, O., Lalor, P. F., Shaw, J., Syn, W., Curbishley, S. M. & Adams, D. H., 7 Jan 2013, In: Hepatology. 57, 1, p. 385-98 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Liver Diseases 100%
  • Monocytes 98%
  • Liver 40%
  • Chemokine CCL1 24%
  • Wound Healing 23%
  139 Citations (Scopus)

• Regulatory T-cell directed therapies in liver diseases

  Oo, Y. H. & Sakaguchi, S., Nov 2013, In: Journal of Hepatology. 59, 5, p. 1127-1134 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  31 Citations (Scopus)

• The regulation of T-cell recruitment to the human liver during acute liver failure

  Tuncer, C., Oo, Y. H., Murphy, N., Adams, D. H. & Lalor, P. F., 25 Apr 2013, (E-pub ahead of print) In: Liver International. 33, 6, p. 852-863

  Research output: Contribution to journal › Article › peer-review

  • Acute Liver Failure 100%
  • Lymphocytes 59%
  • human AOC3 protein 53%
  • Hepatitis 53%
  • T-Lymphocytes 52%
  17 Citations (Scopus)
• 2012

  CD161(+)CD4(+) T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ

  Kang, Y-H., Seigel, B., Bengsch, B., Fleming, V. M., Billerbeck, E., Simmons, R., Walker, L., Willberg, C. B., Barnes, E. J., Bhagwanani, A., Oo, Y. H., Blum, H. E., Adams, D. H., Thimme, R. & Klenerman, P., 20 Nov 2012, In: Frontiers in immunology. 3, 346.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • interleukin-22 100%
  • Chronic Hepatitis 78%
  • T-Lymphocytes 45%
  • Liver 38%
  • Interleukin-17 22%
  21 Citations (Scopus)

• CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver

  Oo, Y. H., Banz, V., Kavanagh, D., Liaskou, E., Withers, D. R., Humphreys, E., Reynolds, G. M., Lee-Turner, L., Kalia, N., Hubscher, S. G., Klenerman, P., Eksteen, B. & Adams, D. H., Nov 2012, In: Journal of Hepatology. 57, 5, p. 1044-1051 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Th17 Cells 100%
  • Liver 62%
  • Interleukin-17 38%
  • Bile Ducts 36%
  • Helper-Inducer T-Lymphocytes 24%
  115 Citations (Scopus)

  268 Downloads (Pure)

• Human MAIT and CD8 alpha alpha cells develop from a pool of type-17 precommitted CD8(+) T cells

  Walker, LJ., Kang, YH., Smith, MO., Tharmalingham, H., Ramamurthy, N., Fleming, VM., Sahgal, N., Leslie, A., Oo, Y. H., Geremia, A., Scriba, TJ., Hanekom, WA., Lauer, GM., Lantz, O., Adams, D., Powrie, F., Barnes, E. & Klenerman, P., 1 Jan 2012, In: Blood. 119, 2, p. 422-433 12 p.

  Research output: Contribution to journal › Article

  • Mucosal-Associated Invariant T Cells 100%
  • T-Lymphocytes 55%
  • Cord 55%
  • Chemokine Receptors 33%
  • Fetal Blood 29%
  182 Citations (Scopus)

• Innate immune cells in liver inflammation

  Liaskou, E., Wilson, D. & Oo, Y. H., 9 Aug 2012, In: Mediators of Inflammation. 2012, 21 p., 949157.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Inflammation 100%
  • Liver 87%
  • Gastrointestinal Tract 59%
  • Immune System 53%
  • Portal Vein 34%
  123 Citations (Scopus)

  210 Downloads (Pure)

• Low-dose interleukin-2 and HCV-induced vasculitis

  Oo, Y. H., Mutimer, D. & Adams, D. H., 5 Apr 2012, In: The New England Journal of Medicine. 366, 14, p. 1353-1354

  Research output: Contribution to journal › Article › peer-review
  6 Citations (Scopus)

• Management of patients with difficult autoimmune hepatitis

  Parker, R., Oo, Y. H. & Adams, D. H., Nov 2012, In: Therapeutic Advances in Gastroenterology. 5, 6, p. 421-437 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Autoimmune Hepatitis 100%
  • HLA-DRB1*03:01 antigen 17%
  • Adrenal Cortex Hormones 15%
  • Hypergammaglobulinemia 13%
  • Therapeutics 12%
  10 Citations (Scopus)

• Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man

  Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., Townsend, R., Brown, A., Antrobus, R., Ammendola, V., Naddeo, M., O'Hara, G., Willberg, C., Harrison, A., Grazioli, F., Esposito, M. L., Siani, L., & 8 othersTraboni, C., Oo, Y. H., Adams, D., Hill, A., Colloca, S., Nicosia, A., Cortese, R. & Klenerman, P., 4 Jan 2012, In: Science Translational Medicine. 4, 115, p. 115ra1

  Research output: Contribution to journal › Article › peer-review

  • Adenovirus Vaccines 100%
  • Hepacivirus 57%
  • T-Lymphocytes 38%
  • Vaccines 13%
  • Genotype 12%
  301 Citations (Scopus)

• Rapid recovery of cytochrome P450 3A4 after protease inhibitor withdrawal in post-liver transplant patients

  Oo, Y. H. & Mutimer, D., 14 Oct 2012, In: Liver Transplantation. 18, 10, p. 1264-5 2 p.

  Research output: Contribution to journal › Article › peer-review
  3 Citations (Scopus)

• Recruitment mechanisms of primary and malignant B cells to the human liver.

  Shetty, S., Bruns, T., Weston, C., Stamataki, Z., Oo, Y. H., Long, H., Reynolds, G., Pratt, G., Moss, P., Jalkanen, S., Hubscher, S., Lalor, P. & Adams, D., 4 Oct 2012, In: Hepatology. 56, 4, p. 1521-1531

  Research output: Contribution to journal › Article

  • B-Lymphocytes 100%
  • Liver 66%
  • Intercellular Adhesion Molecule-1 58%
  • Transendothelial and Transepithelial Migration 49%
  • Lymphoma 46%
  33 Citations (Scopus)

• Regulatory T cells and autoimmune hepatitis: Defective cells or a hostile environment?

  Oo, Y. H. & Adams, D., Jul 2012, In: Journal of Hepatology. 57, 1, p. 6-8

  Research output: Contribution to journal › Article

  Open Access
  24 Citations (Scopus)